{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:06:00Z","timestamp":1649088360188},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T00:00:00Z","timestamp":1291680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11845-010-0654-4","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T09:01:35Z","timestamp":1291626095000},"page":"125-128","source":"Crossref","is-referenced-by-count":2,"title":["Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients"],"prefix":"10.1007","volume":"180","author":[{"given":"S.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Abuzakouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A. C.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,7]]},"reference":[{"issue":"4","key":"654_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7861\/clinmedicine.6-4-356","volume":"6","author":"T El-Shanawany","year":"2006","unstructured":"El-Shanawany T, Sewell WA, Misbah SA, Jolles S (2006) Current clinical uses of intravenous immunoglobulin. Clin Med 6(4):356\u2013359","journal-title":"Clin Med"},{"issue":"6","key":"654_CR2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaci.2008.08.033","volume":"122","author":"FA Bonilla","year":"2008","unstructured":"Bonilla FA (2008) Intravenous immunoglobulin: adverse reactions and management. J Allergy Clin Immunol 122(6):1238\u20131239","journal-title":"J Allergy Clin Immunol"},{"key":"654_CR3","unstructured":"UK-Primary Immunodeficiency Network (UKPIN) guideline 2.01. Administration of IVIG. http:\/\/www.ukpin.org.uk\/guidelines5-01.html . Accessed 5 May 2009"},{"issue":"2","key":"654_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","volume":"133","author":"VM Brennan","year":"2003","unstructured":"Brennan VM, Salom\u00e9-Bentley NJ, Chapel HM (2003) Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol 133(2):247\u2013251","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"654_CR5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93(3):190\u2013197","journal-title":"Clin Immunol"},{"issue":"4 Suppl","key":"654_CR6","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"JS Orange","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR et al (2006) Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma, Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma, Immunology. J Allergy Clin Immunol 117(4 Suppl):S525\u2013S553","journal-title":"J Allergy Clin Immunol"},{"issue":"3A","key":"654_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(84)90316-4","volume":"76","author":"NK Day","year":"1984","unstructured":"Day NK, Good RA, Wahn V (1984) Adverse reactions in selected patients following intravenous infusions of gamma globulin. Am J Med 76(3A):25\u201332","journal-title":"Am J Med"},{"issue":"31\u201332","key":"654_CR8","first-page":"795","volume":"102","author":"V Wahn","year":"1984","unstructured":"Wahn V (1984) Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors. Fortschr Med 102(31\u201332):795\u2013798","journal-title":"Fortschr Med"},{"issue":"4","key":"654_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/02813430802214470","volume":"26","author":"H Lingard","year":"2008","unstructured":"Lingard H, Zehetmayer S, Maier M (2008) Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow-up in primary care. Scand J Prim Health Care 26(4):211\u2013215","journal-title":"Scand J Prim Health Care"},{"issue":"506","key":"654_CR10","first-page":"653","volume":"54","author":"H Melbye","year":"2004","unstructured":"Melbye H, Hvidsten D, Holm A, Nordb\u00f8 SA, Brox J (2004) The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract 54(506):653\u2013658","journal-title":"Br J Gen Pract"},{"issue":"8","key":"654_CR11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jcp.55.8.577","volume":"55","author":"SJ Pettit","year":"2002","unstructured":"Pettit SJ, Bourne H, Spickett GP (2002) Survey of infection in patients receiving antibody replacement treatment for immune deficiency. J Clin Pathol 55(8):577\u2013580","journal-title":"J Clin Pathol"},{"issue":"9","key":"654_CR12","doi-asserted-by":"crossref","first-page":"e1000341","DOI":"10.1371\/journal.pmed.1000341","volume":"7","author":"B Rhodes","year":"2010","unstructured":"Rhodes B, Merriman ME, Harrison A et al (2010) A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 7(9):e1000341","journal-title":"PLoS Med"},{"key":"654_CR13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bmj.a1831","volume":"337","author":"D Provan","year":"2008","unstructured":"Provan D, Chapel HM, Sewell WAC, O\u2019Shaughnessy D (2008) Prescribing intravenous immunoglobulin: summary of Department of Health Guidelines. BMJ 337:990\u2013992","journal-title":"BMJ"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-010-0654-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-010-0654-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-010-0654-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:09:31Z","timestamp":1559430571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-010-0654-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,7]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s11845-010-0654-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,7]]}}}